Navigation Links
CTI Issues Statement Regarding Tosedostat Clinical Trial
Date:6/24/2013

l rate of 51 percent. Subset analyses suggested the greatest benefit occurred in the difficult-to-treat patients with prior myelodysplastic syndrome (MDS) or those that had received prior hypomethylating therapy (HMA). Adverse events were mild, predictable and manageable.

About Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Approximately 14,590 new cases of AML were expected to be diagnosed in the United States in 2013.1 As of January 2008 an estimated 30,993 people were living with (or were in remission from) AML.2 Although AML can occur at any age, adults aged 60 years and older are more likely to develop the disease than younger people. AML is a cancer characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells. AML may develop from the progression of other diseases such as myelodysplastic syndrome (MDS), a blood cancer that also affects the bone marrow leading to a decrease in circulating red blood cells. AML is the most common acute leukemia affecting adults, and its incidence increases with age. The symptoms of AML are caused by replacement of normal bone marrow with leukemic cells, which causes a drop in red blood cells, platelets, and normal white blood cells leading to infections and bleeding. AML progresses rapidly and is typically fatal within weeks or months if left untreated. Although a substantial proportion of younger individuals who develop AML can be cured, AML in the elderly typically responds poorly to standard therapy with few complete remissions.

About CTI
Cell Therapeutics, Inc. (NASDAQ and MTA: CTIC) is a biopharmaceutical company committed to the development and commercialization of an integrated portfolio of oncology products aimed at making cancer more treatable. CTI is headquartered in Seattle, WA. For additional information and to si
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
2. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
3. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
4. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
5. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
6. ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials
7. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
8. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
9. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
10. BD Issues 2012 Sustainability Report
11. TNI BioTech, Inc. Corporations CEO Issues Letter to Shareholders Discussing Recent Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015  The investigational S- ... alleviate certain menopause symptoms, such as hot flashes, according ... Journal of Women,s Health .[i] "Current data ... equol for menopausal vasomotor symptoms and possibly additional benefits, ... of S- equol, physicians and health care professionals ...
(Date:3/30/2015)... March 30, 2015  A promising University of Michigan ... with a rare and lethal subtype of leukemia has ... with a new biotechnology company, Kura Oncology.  The Leukemia ... led by Assistant Professor Jolanta Grembecka , Ph.D, ... the University of Michigan, since 2009. ...
(Date:3/30/2015)... MINNEAPOLIS and ORANGEBURG, N.Y., March 30, 2015 ... Inc. (NASDAQ: VSCI ) shareholders have voted ... held today to approve the previously announced agreement ... "We are pleased with the outcome ... to thank both shareholder groups for approving the ...
Breaking Medicine Technology:New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 2New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 3New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 5New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 6Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4
(Date:3/30/2015)... 2015 Innovaacom, a leading provider of ... announced it is expanding its services into Asia in ... of the world comes at a time when Asia’s ... for better healthcare. A rapidly growing aging population and ... advances in medicine in Asia. “We are excited to ...
(Date:3/30/2015)... March 30, 2015 On March 29, 2015 ... Day. In honor of all small business owners, for their ... spotlighting them. , According to Zane Benefits' website, small ... economy, creating 75% of all jobs and employing over 60 ... for 54% of all U.S. sales. The small business sector ...
(Date:3/30/2015)... On March 19th, 2015, in the ... the Detroit Lions, LiveToBeSober.org hosted the “Fighting Addiction Together” ... and bishops as well as other civic leaders and ... the luncheon, including retired Detroit Lions wide receiver Herman ... two survivors of their own personal battles with addiction, ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Valerie Harper, ... 1970s sitcoms “Rhoda” and “The Mary Tyler Moore Show,” ... ceremony honoring oncology nurses, CURETM magazine announced today. Harper, ... of the Oncology Nursing Society’s 40th Annual Congress on ... the important role oncology nurses play in the lives ...
(Date:3/30/2015)... York, NY (PRWEB) March 30, 2015 V/NO ... that includes a convenient flute for opening/closing and for reuse. ... wine on the go. Health-conscious New Yorkers, professionals, and basically ... is sophisticated yet delicious to kick back socially or pair ... arise. , “ V/NO is dealcoholized wine and that ...
Breaking Medicine News(10 mins):Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:Zane Benefits Puts Spotlight on Small Businesses for National Mom and Pop Business Owners Day 2Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 3Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2
... Oct. 18 The following statement,is attributable to: ... American Medical Association (AMA) welcomes today,s decision by,New ... a consumer warning,about the potentially deceptive programs used ... AMA is committed to the goal of empowering ...
... Chorus: ,It Takes A Village, October 27 and 28, ... Sing, a,not-for-profit organization founded by Chicago resident Melinda Pollack,was ... a,musical outlet for singers whose lives have been touched ... that celebrates hope and survival,provides its singers a venue ...
... Oct. 18 West Pharmaceutical,Services, Inc. (NYSE: ... announcement that it has decided to discontinue marketing ... to the,Company,s customer, Nektar Therapeutics, Inc. The Company,s ... the Exubera inhalation device for Nektar. "We ...
... of,Dental Plans (NADP) calls on Congress and the Administration ... (CHIP).,Specifically, NADP urges prompt action to enact the dental ... In letters to congressional health policy leaders, NADP ... services should be a mandatory CHIP benefit. ...
... SANTA CLARA, Calif., Oct. 18 Align,Technology, Inc. ... a proprietary,method of straightening teeth without wires or ... by the Academy of General,Dentistry,s (AGD) Program Approval ... evaluation of the educational processes used in designing,planning ...
... Surgical Care Affiliates,(SCA) has named Ali Reza as its ... responsible for a variety of ongoing initiatives and,projects as ... are pleased to bring someone with Ali,s experience to ... "His previous work,in the areas of operational turnaround and ...
Cached Medicine News:Health News:Breast Cancer Survivors and Their Supporters 'Sing to Live' 2Health News:West Pharmaceutical Services Issues Statement on Exubera 2Health News:West Pharmaceutical Services Issues Statement on Exubera 3Health News:West Pharmaceutical Services Issues Statement on Exubera 4Health News:NADP Calls on Congress and the White House to Work Together to Cover Children's Dental Health 2Health News:Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry 2Health News:Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry 3